Literature DB >> 9060669

Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats.

X S Wang1, K Qing, S Ponnazhagan, A Srivastava.   

Abstract

The adeno-associated virus type 2 (AAV) genome contains inverted terminal repeats (ITRs) of 145 nucleotides. The terminal 125 nucleotides of each ITR form palindromic hairpin (HP) structures that serve as primers for AAV DNA replication. These HP structures also play an important role in integration as well as rescue of the proviral genome from latently infected cells or from recombinant AAV plasmids. Each ITR also contains a stretch of 20 nucleotides, designated the D sequence, that is not involved in HP structure formation. We have recently shown that the D sequence plays a crucial role in high-efficiency rescue, selective replication, and encapsidation of the AAV genome and that a host cell protein, designated the D sequence-binding protein (D-BP), specifically interacts with this sequence (X.-S. Wang, S. Ponnazhagan, and A. Srivastava, J. Virol. 70:1668-1677, 1996). We have now performed mutational analyses of the D sequences to evaluate their precise role in viral DNA rescue, replication, and packaging. We report here that 10 nucleotides proximal to the HP structure in each of the D sequences are necessary and sufficient to mediate high-efficiency rescue, replication, and encapsidation of the viral genome in vivo. In in vitro studies, the same 10 nucleotides were found to be required for specific interaction with D-BP, but viral Rep protein-mediated cleavage at the functional terminal resolution site is independent of these sequences. These data suggest that AAV replication and terminal resolution functions can be uncoupled and that the lack of efficient replication of AAV DNA may not be a consequence of impaired resolution of the viral ITRs. These studies further illustrate that the D sequence-D-BP interaction plays an important role in the AAV life cycle and indicate that it may be possible to develop the next generation of AAV vectors capable of encapsidating larger pieces of DNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060669      PMCID: PMC191438     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Replication of the adeno-associated virus DNA termini in vitro.

Authors:  A Srivastava
Journal:  Intervirology       Date:  1987       Impact factor: 1.763

2.  Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA.

Authors:  H Ashktorab; A Srivastava
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

Review 3.  Adeno-associated viruses: an update.

Authors:  K I Berns; R A Bohenzky
Journal:  Adv Virus Res       Date:  1987       Impact factor: 9.937

4.  Binding of the herpes simplex virus immediate-early gene product ICP4 to its own transcription start site.

Authors:  M T Muller
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

Review 5.  Regulation of adeno-associated virus DNA replication.

Authors:  K I Berns; R M Kotin; M A Labow
Journal:  Biochim Biophys Acta       Date:  1988-12-20

6.  In vitro resolution of covalently joined AAV chromosome ends.

Authors:  R O Snyder; R J Samulski; N Muzyczka
Journal:  Cell       Date:  1990-01-12       Impact factor: 41.582

7.  In vitro excision of adeno-associated virus DNA from recombinant plasmids: isolation of an enzyme fraction from HeLa cells that cleaves DNA at poly(G) sequences.

Authors:  J Gottlieb; N Muzyczka
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

8.  Rescue and replication of the adeno-associated virus 2 genome in mortal and immortal human cells.

Authors:  P Nahreini; A Srivastava
Journal:  Intervirology       Date:  1989       Impact factor: 1.763

9.  Organization of adeno-associated virus DNA in latently infected Detroit 6 cells.

Authors:  R M Kotin; K I Berns
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

10.  Factors that bind to adeno-associated virus terminal repeats.

Authors:  D S Im; N Muzyczka
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

View more
  27 in total

1.  Undetectable transcription of cap in a clinical AAV vector: implications for preformed capsid in immune responses.

Authors:  Bernd Hauck; Samuel L Murphy; Peter H Smith; Guang Qu; Xingge Liu; Olga Zelenaia; Federico Mingozzi; Jürg M Sommer; Katherine A High; J Fraser Wright
Journal:  Mol Ther       Date:  2008-10-21       Impact factor: 11.454

2.  Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.

Authors:  X S Wang; B Khuntirat; K Qing; S Ponnazhagan; D M Kube; S Zhou; V J Dwarki; A Srivastava
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

3.  Rescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter.

Authors:  X S Wang; A Srivastava
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  Adeno-Associated Virus Vector Mobilization, Risk Versus Reality.

Authors:  Liujiang Song; R Jude Samulski; Matthew L Hirsch
Journal:  Hum Gene Ther       Date:  2020-10       Impact factor: 5.695

5.  A cis-acting element that directs circular adeno-associated virus replication and packaging.

Authors:  Sergei Musatov; Jill Roberts; Donald Pfaff; Michael Kaplitt
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Novel transcriptional regulatory signals in the adeno-associated virus terminal repeat A/D junction element.

Authors:  R P Haberman; T J McCown; R J Samulski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression.

Authors:  K Qing; X S Wang; D M Kube; S Ponnazhagan; A Bajpai; A Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

8.  Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb.

Authors:  Yi Lai; Yongping Yue; Dongsheng Duan
Journal:  Mol Ther       Date:  2009-11-10       Impact factor: 11.454

9.  Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene expression.

Authors:  D Duan; P Sharma; L Dudus; Y Zhang; S Sanlioglu; Z Yan; Y Yue; Y Ye; R Lester; J Yang; K J Fisher; J F Engelhardt
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.

Authors:  Giridhara R Jayandharan; Li Zhong; Brandon K Sack; Angela E Rivers; Mengxin Li; Baozheng Li; Roland W Herzog; Arun Srivastava
Journal:  Hum Gene Ther       Date:  2010-03       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.